Table Of Contents:
- Chapter 1. Research Methodology and Scope
- Market Segmentation and Scope
- Regional Coverage
- Objectives
- Research Methodology
- Chapter 2. Executive Summary
- Market Landscape
- Market Size & Forecast
- Competitive Landscape
- Chapter 3. Amyotrophic Lateral Sclerosis (ALS) Market: By Drug Class Trends, Size, and Future Outlook
- By Drug Class Market Size (US$), CAGR (%), and Forecast (2023-2031)
- By Drug Class Definitions, Technology Landscape
- By Drug Class Market Drivers
- Product Launches
- Technology Launches
- By Drug Class Market Restraints
- Chapter 4. Amyotrophic Lateral Sclerosis (ALS) Market: By Route of Administration Trends, Size, and Future Outlook
- By Route of Administration Market Size (US$), CAGR (%), and Forecast (2023-2031)
- By Route of Administration Definitions, Technology Landscape
- By Route of Administration Market Drivers
- Product Launches
- Technology Launches
- By Route of Administration Market Restraints
- Chapter 5. Amyotrophic Lateral Sclerosis (ALS) Market: By Distribution Channel Trends, Size, and Future Outlook
- By Distribution Channel Market Size (US$), CAGR (%), and Forecast (2023-2031)
- By Distribution Channel Definitions, Technology Landscape
- By Distribution Channel Market Drivers
- Product Launches
- Technology Launches
- By Distribution Channel Market Restraints
- Chapter 6. Amyotrophic Lateral Sclerosis (ALS) Market: By End-User Trends, Size, and Future Outlook
- By End-User Market Size (US$), CAGR (%), and Forecast (2023-2031)
- By End-User Definitions, Technology Landscape
- By End-User Market Drivers
- Product Launches
- Technology Launches
- By End-User Market Restraints
- Chapter 7. Amyotrophic Lateral Sclerosis (ALS) Market: By Disease Type Trends, Size, and Future Outlook
- By Disease Type Market Size (US$), CAGR (%), and Forecast (2023-2031)
- By Disease Type Definitions, Technology Landscape
- By Disease Type Market Drivers
- Product Launches
- Technology Launches
- By Disease Type Market Restraints
- Chapter 8. Amyotrophic Lateral Sclerosis (ALS) Market: By Mechanism of Action Trends, Size, and Future Outlook
- By Mechanism of Action Market Size (US$), CAGR (%), and Forecast (2023-2031)
- By Mechanism of Action Definitions, Technology Landscape
- By Mechanism of Action Market Drivers
- Product Launches
- Technology Launches
- By Mechanism of Action Market Restraints
- Chapter 9. Amyotrophic Lateral Sclerosis (ALS) Market: Regional Market Trends, Size, and Future Outlook
- North America Trends, Market Size (US$), CAGR (%), and Future Outlook
- North America Market Size (US$), CAGR (%), and Forecast (2023-2031)
- North America Definitions, Technology Landscape
- North America Market Drivers
- Product Launches
- Technology Launches
- North America Market Restraints
- Competitive Outlook
- Europe Trends, Market Size (US$), CAGR (%), and Future Outlook
- Europe Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Europe Definitions, Technology Landscape
- Europe Market Drivers
- Product Launches
- Technology Launches
- Europe Market Restraints
- Competitive Outlook
- Asia Pacific Trends, Market Size (US$), CAGR (%), and Future Outlook
- Asia Pacific Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Asia Pacific Definitions, Technology Landscape
- Asia Pacific Market Drivers
- Product Launches
- Technology Launches
- Asia Pacific Market Restraints
- Competitive Outlook
- Latin America Trends, Market Size (US$), CAGR (%), and Future Outlook
- Latin America Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Latin America Definitions, Technology Landscape
- Latin America Market Drivers
- Product Launches
- Technology Launches
- Latin America Market Restraints
- Competitive Outlook
- Middle East & Africa Trends, Market Size (US$), CAGR (%), and Future Outlook
- Middle East & Africa Market Size (US$), CAGR (%), and Forecast (2023-2031)
- Middle East & Africa Definitions, Technology Landscape
- Middle East & Africa Market Drivers
- Product Launches
- Technology Launches
- Middle East & Africa Market Restraints
- Competitive Outlook
- North America Trends, Market Size (US$), CAGR (%), and Future Outlook
Chapter 10. Amyotrophic Lateral Sclerosis (ALS) Market: Competitive Landscape
- Mitsubishi Tanabe Pharma Corporation
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Biogen Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Ionis Pharmaceuticals, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Cytokinetics, Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Orion Pharma
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Apotex Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
- Bausch Health Companies Inc.
- Company Overview
- Financial Outlook
- Product Portfolio
- Strategies
Research Methodology
- Primary Research
- Secondary Research
- Assumptions
- IDataAcumen Analysis
- Paid Databases
Appendix
- About Us
Frequently Asked Questions
The current market size of the Amyotrophic Lateral Sclerosis (ALS) industry is US$ 630 million.
The increasing prevalence of ALS due to an aging population, advancements in diagnostic techniques, growing research and development efforts, rising awareness and support initiatives, and the development of novel therapies are the key factors driving the growth of the Amyotrophic Lateral Sclerosis (ALS) market.
The high cost of treatment, limited approved therapeutic options, stringent regulatory approval processes, and the lack of disease-modifying therapies are the primary factors hampering the growth of the Amyotrophic Lateral Sclerosis (ALS) market.
The leading component segment in the Amyotrophic Lateral Sclerosis (ALS) Market is the riluzole segment, as it is the only FDA-approved drug for ALS.
The major players operating in the Amyotrophic Lateral Sclerosis (ALS) Market include Mitsubishi Tanabe Pharma Corporation, Biogen Inc., Ionis Pharmaceuticals, Inc., Cytokinetics, Inc., Orion Pharma, Apotex Inc., Sun Pharmaceutical Industries Ltd., and Bausch Health Companies Inc.
The CAGR of the Amyotrophic Lateral Sclerosis (ALS) Market for the forecast period of 2024-2031 is 9.8%, and the market size is expected to reach US$ 1,330.9 million by 2031.
The increasing prevalence of ALS, advancements in diagnostic techniques, growing research and development efforts, rising awareness and support initiatives, and the development of novel therapies are the key drivers of the Amyotrophic Lateral Sclerosis (ALS) Market.